This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Whitehurst AW, Xie Y, Purinton SC, Cappell KM, Swanik JT, Larson B, et al. Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation. Cancer Res. 2010; 70:7652–61.WhitehurstAWXieYPurintonSCCappellKMSwanikJTLarsonBTumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation20107076526110.1158/0008-5472.CAN-10-0840294862720876808Search in Google Scholar
Stamm S, Smith C, Lührmann R, editors. Alternative pre-mRNA splicing: theory and protocols. Weinheim, Germany: Wiley-VCH Verlag; 2012.StammSSmithCLührmannReditorsWeinheim, GermanyWiley-VCH Verlag201210.1002/9783527636778Search in Google Scholar
Hemminger JA, Toland AE, Scharschmidt TJ, Mayerson JL, Guttridge DC, Iwenofu OH. Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma. Mod Pathol. 2014; 27:1238–45.HemmingerJATolandAEScharschmidtTJMayersonJLGuttridgeDCIwenofuOHExpression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma20142712384510.1038/modpathol.2013.244428722924457462Search in Google Scholar
Luo B, Yun X, Lin YD, Xiao SW, Yan GH, He SJ, et al. [Construction of eukaryotic expression vector encoding ACRBP and its expression in hepatocarcinoma cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi [Chinese Journal of Cellular and Molecular Immunology]. 2011; 27:1072–4. [in Chinese, English abstract].LuoBYunXLinYDXiaoSWYanGHHeSJ[Construction of eukaryotic expression vector encoding ACRBP and its expression in hepatocarcinoma cells]20112710724[in Chinese, English abstract].Search in Google Scholar
Luo B, Yun X, Fan R, Lin Y-D, He S-J, Zhang Q-M, et al. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters. Int J Clin Exp Pathol. 2013; 6:2835–45.LuoBYunXFanRLinY-DHeS-JZhangQ-MCancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters20136283545Search in Google Scholar
Li X, Yan J, Fan R, Luo B, Zhang Q, Lin Y, et al. Serum immunore-activity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma. Oncol Lett. 2017; 13:3080–6.LiXYanJFanRLuoBZhangQLinYSerum immunore-activity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma2017133080610.3892/ol.2017.5799543167428529561Search in Google Scholar
Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci U S A. 2001; 98:3282–7.OnoTKurashigeTHaradaNNoguchiYSaikaTNiikawaNIdentification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen2001983282710.1073/pnas.0416250983064511248070Search in Google Scholar
Kazemi-Oula G, Ghafouri-Fard S, Mobasheri MB, Geranpayeh L, Modarressi MH. Upregulation of RHOXF2 and ODF4 expression in breast cancer tissues. Cell J. 2015; 17:471–7.Kazemi-OulaGGhafouri-FardSMobasheriMBGeranpayehLModarressiMHUpregulation of RHOXF2 and ODF4 expression in breast cancer tissues2015174717Search in Google Scholar
Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017; 18:437–51.BaralleFEGiudiceJAlternative splicing as a regulator of development and tissue identity2017184375110.1038/nrm.2017.27683988928488700Search in Google Scholar
Zheng B. Expression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors. Asian Biomed (Research Review News). 2020: 14(6);243–52.ZhengBExpression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors20201462435210.1515/abm-2020-0033Search in Google Scholar
Urbanski LM, Leclair N, Anczuków O. Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA. 2018; 9:e1476. doi: 10.1002/wrna.1476UrbanskiLMLeclairNAnczukówOAlternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics20189e147610.1002/wrna.1476600293429693319Open DOISearch in Google Scholar